Broderick, Lori https://orcid.org/0000-0001-6147-7097
Hoffman, Hal M. https://orcid.org/0000-0001-8609-2548
Article History
Accepted: 20 May 2022
First Online: 21 June 2022
Change Date: 23 May 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41584-024-01128-2
Competing interests
: L.B. is a site PI for Novartis, Inc. H.M.H. is a consultant for Novartis and Kiniksa, H.M.H. has research collaborations with Regeneron, Inc.; Jecure, Inc., Zomagen, Inc., Takeda.